PPD S2 (Aplisol®) |
JHP Pharmaceuticals, Inc, Rochester, MI, USA |
5 TU |
(Villarino, et al., 1999) |
PPD S2 (Tubersol®) |
Sanofi Pasteur Limited, Swiftwater, PA, USA |
5 TU |
(Villarino, et al., 1999, Teixeira, et al., 2000, Rangel-Frausto, et al., 2001) |
PPD RT23 SSI |
Statens Serum Institute, Copenhagen, Denmark |
2 TU |
(Maes, et al., 2011, Teixeira, et al., 2000) |
PPD RT23 Mexico |
Laboratorio Nacional de Salud, Secretaria de Salud, Mexico City, Mexico |
2 TU |
(Rangel-Frausto, et al., 2001) |
PPD RT23 (Evans PPD) |
Celltech Pharma S.A., Madrid, Spain |
2 TU |
(Fernandez-Villar, et al., 2004) |
PPD-s |
Nihon BCG Seizo Co., Tokyo, Japan |
3 TU |
(Shigeto, 1990) |
PPD IC-65 |
Cantacuzino Institute, Bucharest, Romania |
2 TU |
(Ulea, et al. 2010) |